Veraxa Biotech Holding AG (VRXA) Equity Average (2025)
Veraxa Biotech Holding AG (VRXA) posted Equity Average of -$61.7 million for Q4 2025.
Veraxa Biotech Holding AG (VRXA) Equity Average (2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Equity Average for 1 consecutive years, with -$61.7 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Equity Average changed N/A year-over-year to -$61.7 million; the trailing twelve-month figure through Dec 2025 stood at -$61.7 million (changed N/A YoY), and the FY2025 full-year result was -$61.7 million, changed N/A from the prior year.
- Equity Average steadied at -$61.7 million in Q4 2025 per VRXA's latest filing.
- In the past five years, Equity Average ranged from a high of -$61.7 million in Q4 2025 to a low of -$61.7 million in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -61.73 Mn |